Litcius/Paper detail

Leflunomide–hydroxychloroquine combination therapy in patients with primary Sjögren's syndrome (RepurpSS-I): a placebo-controlled, double-blinded, randomised clinical trial

Eefje Hanna Martine van der Heijden, Sofie Liny Marie Blokland, Maarten R. Hillen, Ana P. Lopes, Fréderique M van Vliet-Moret, Antoine J.W.P. Rosenberg, Nard G. Janssen, Paco Mattheus Jacobus Welsing, Valentina Iannizzotto, Weiyang Tao, Aridaman Pandit, Francesca Barone, Aike A. Kruize, Timothy Ruben Dirk Jan Radstake, Joël A. G. van Roon

2020The Lancet Rheumatology91 citationsDOIOpen Access PDF

Topics & Concepts

HydroxychloroquineMedicineLeflunomidePlaceboInternal medicineClinical endpointRheumatismRheumatologyClinical trialSurgeryRheumatoid arthritisDiseasePathologyCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)Alternative medicineSalivary Gland Disorders and FunctionsSystemic Lupus Erythematosus ResearchRheumatoid Arthritis Research and Therapies